Back to publication

Does receiving a SARS-CoV-2 antibody test result change COVID-19 protective behaviors? Testing risk compensation in undergraduate students with a randomized controlled trial

Assessed by RV006 · Research Assistant/Biostatistician

Assessed on 4 Nov 2025

OverallReviewer's overall integrity assessment, derived from all research questions Some concerns

DOI 10.1371/journal.pone.0279347 (opens in new tab)

Resource ripekg:research-integrity-assessment/RIPEAEADB33420805D4F9

5 Research Questions · 23 Evidence Items

Q1.1 — Does the study have an associated retraction?

Automated Assessment:Assessment produced by the automated systemNo
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsNo

Rationale: No rationale provided

Q1.2 — Does the study have an associated expression of concern or other relevant post-publication notice?

Automated Assessment:Assessment produced by the automated systemNo
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsNo

Rationale: No rationale provided

Q1.3 — Do other studies by the research team highlight causes for concern?

Automated Assessment:Assessment produced by the automated systemYes
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsYes

Rationale: Yes, 1 record for David B Allison. But not for Chen, the 20 retractions are for other Chen Chens(same name) not for this co-author.

Supporting Evidence (21)

Retraction NoticeSource: Retraction Watch database

An African Ancestry-specific Allele of CTLA4 Confers Protection Against rheumatoid Arthritis in African Americans

10.1371/annotation/80bd7285-9d2d-403a-8e6f-9c375bf977ca (opens in new tab)
Journal: PLoS GeneticsPublisher: PLoSDate: 1 Dec 2009

RetractionWatch ID:Record identifier in the Retraction Watch database 1945

Rationale: Error in Data;Results Not Reproducible;Unreliable Data;Unreliable Results and/or Conclusions

About Author: David Allison

Retraction NoticeSource: Retraction Watch database

Levetiracetam inhibits THP-1 monocyte chemotaxis and adhesion via the synaptic vesicle 2A

10.1016/j.bbrc.2021.10.012 (opens in new tab)
Journal: Biochemical and Biophysical Research Communications (BBRC)Publisher: ElsevierDate: 10 Nov 2021

RetractionWatch ID:Record identifier in the Retraction Watch database 34054

Rationale: Concerns/Issues about Results and/or Conclusions;Unreliable Results and/or Conclusions

About Author: Chen Chen

Retraction NoticeSource: Retraction Watch database

Intelligent driving system of robot based on computer vision and neural network algorithm

10.3233/jifs-219218 (opens in new tab)
Journal: Journal of Intelligent & Fuzzy SystemsPublisher: IOS Press (bought by Sage November 2023)Date: 17 Nov 2021

RetractionWatch ID:Record identifier in the Retraction Watch database 34216

Rationale: Concerns/Issues about Referencing/Attributions;Investigation by Journal/Publisher;Investigation by Third Party;Removed

About Author: Chen Chen

Q2.2 — Are there concerns relating to the timing or absence of study registration?

Automated Assessment:Assessment produced by the automated systemYes
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsYes

Rationale: Registration date 11/5/2020 is after the recruitment start date 9/14/2020.

Supporting Evidence (2)

Clinical Trial RegistrationSource: Clinical trial registry (e.g. ClinicalTrials.gov, ISRCTN)

Registration ID: NCT04620798

Registry: ClinicalTrials.gov

Registry Link: https://clinicaltrials.gov/study/NCT04620798 (opens in new tab)

Registration Date: 05-11-2020

Prospective:Whether the trial was registered before participant recruitment began No

Assessment Rationale:How INSPECT-AI determined the prospective registration status by comparing dates Registration date is after LLM recruitment start date.

Study Design EvidenceDates and timelines extracted by INSPECT-AI from the publication text

Recruitment Start: 14-09-2020

Recruitment Start Rationale:INSPECT-AI's reasoning for how it identified the recruitment start date Methods: 'Participants attended an in-person clinic visit for baseline antibody testing between September 14 and 30, 2020...'; using the earlier date as the recruitment start date.

Recruitment End: 30-09-2020

Recruitment End Rationale:INSPECT-AI's reasoning for how it identified the recruitment end date Methods: 'Participants attended an in-person clinic visit for baseline antibody testing between September 14 and 30, 2020...'; using the later date as the recruitment finish date.

Study End: 14-11-2020

Study End Rationale:INSPECT-AI's reasoning for how it identified the study end date Methods: 'Participants attended an in-person clinic visit for baseline antibody testing between September 14 and 30, 2020, and again for a second antibody test between November 8-14, 2020.'; using the later date as the study end date.

Overall — What is the overall integrity assessment of the study?

Automated Assessment:Assessment produced by the automated systemN/A
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsSome concerns

Rationale: It is a retrospective (45 days) registration, which is after the first recruitment date.